Literature DB >> 32574099

Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi.

Daphne Gadama1, Tisungane Mvalo1,2, Amy Sarah Ginsburg3.   

Abstract

High vaccination coverage with Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines is critical to addressing childhood pneumonia's high mortality. The Innovative Treatments in Pneumonia project in Lilongwe, Malawi collected Hib and pneumococcal vaccination information from children's health passports and found the majority demonstrated inadequate and inconsistent documentation. We were unable to confidently assess the impact of Hib and pneumococcal vaccination on pneumonia treatment failure in our study population. Whether it be that enrolled children did not receive age-eligible vaccines or there was poor vaccination record-keeping, we do not know. A shift to an electronic data collection system may help ensure capture of essential vaccination data and provide more accurate records of both individual and population vaccination coverage in Malawi.

Entities:  

Keywords:  Pneumococcal vaccine; children; pneumonia; vaccination

Year:  2020        PMID: 32574099      PMCID: PMC7899636          DOI: 10.1080/21645515.2020.1773142

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  8 in total

1.  Factors associated with non- and under-vaccination among children aged 12-23 months in Malawi. A multinomial analysis of the population-based sample.

Authors:  Peter Austin Morton Ntenda
Journal:  Pediatr Neonatol       Date:  2019-03-21       Impact factor: 2.083

2.  Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.

Authors:  Hazzie Mvula; Ellen Heinsbroek; Menard Chihana; Amelia C Crampin; Storn Kabuluzi; Geoffrey Chirwa; Charles Mwansambo; Anthony Costello; Nigel A Cunliffe; Robert S Heyderman; Neil French; Naor Bar-Zeev
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

3.  Challenges of immunization in the African Region.

Authors:  Richard Mihigo; Joseph Okeibunor; Blanche Anya; Pascal Mkanda; Felicitas Zawaira
Journal:  Pan Afr Med J       Date:  2017-06-21

4.  An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi.

Authors:  Austin Bondo; Bejoy Nambiar; Norman Lufesi; Rashid Deula; Carina King; Gibson Masache; Charles Makwenda; Anthony Costello; Dale Rhoda; Eric D McCollum; Tim Colbourn
Journal:  Gates Open Res       Date:  2018-08-02

5.  Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.

Authors:  Amy Sarah Ginsburg; Tisungane Mvalo; Evangelyn Nkwopara; Eric D McCollum; Chifundo B Ndamala; Robert Schmicker; Ajib Phiri; Norman Lufesi; Rasa Izadnegahdar; Susanne May
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

6.  Towards a Strategy for Reducing Missed Opportunities for Vaccination in Malawi: Implications of a Qualitative Health Facility Assessment.

Authors:  Joseph C Okeibunor; Ikechukwu Ogbuanu; Anya Blanche; Kwame Chiwaya; Geoffrey Chirwa; Zorodzai Machekanyanga; Richard Mihigo; Felicitas Zawaira
Journal:  J Immunol Sci       Date:  2018-07-02

7.  Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study "Innovative Treatments in Pneumonia".

Authors:  Amy Sarah Ginsburg; Susanne May; Evangelyn Nkwopara; Gwen Ambler; Eric D McCollum; Tisungane Mvalo; Ajib Phiri; Norman Lufesi
Journal:  JMIR Res Protoc       Date:  2019-07-29

8.  Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.

Authors:  Amy Sarah Ginsburg; Susanne J May; Evangelyn Nkwopara; Gwen Ambler; Eric D McCollum; Tisungane Mvalo; Ajib Phiri; Norman Lufesi; Salim Sadruddin
Journal:  BMC Infect Dis       Date:  2018-09-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.